InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Mark Hopman. Officer active across 1 company, notably Beta Bionics, Inc.. In total, 5 filings have been logged. Activity tracked since 2 June 2026. The latest transaction was filed on 9 September 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Mark Hopman is an insider linked to Beta Bionics, Inc. (XNAS) as an Officer. Across 4 filings in total, the 4 sampled filings cover the period from 2026-06-03 to 2026-09-03 and consist only of sales, totaling EUR 167438, with notice of proposed sale (Form 144) as the most frequent transaction type.